Content of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral mucosa and inflamed periodontal tissue

Quintessence International

Volumn 41, Issue 2, 2010, Pages 165-171

  Deppe, Herbert ^a   Hohlweg Majert, Bettina ^a   Hölzle, Frank ^a   Kesting, Marco R ^a   Wagenpfeil, Stefan ^a   Wolff, Klaus Dietrich ^a   Schmitt, Manfred ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

PAI 1; Periodontitis; Plasminogen activator inhibitor; Serine proteases; Upa; Urokinase type plasminogen activator; Widman flaps

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CHRONIC PERIODONTITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; NONPARAMETRIC TEST;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHRONIC PERIODONTITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; PLASMINOGEN ACTIVATOR INHIBITOR 1; STATISTICS, NONPARAMETRIC; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 79951961982     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Theilade E, Wright WH, Jensen SB, Loe HE. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. J Periodontal Res 1966;1: 1-13.
2. McGuire MK, Nunn ME. Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J Periodontol 1999; 70: 49-56.
3. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25: 134-144.
4. Agis H, Bauer M, Knebl G, Watzek G, Gruber R. Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts. J Periodontal Res 2008;43: 334-342.
5. Sarajlic J, Agis H, Kandler B, Watzek G, Gruber R. Plasminogen activation by fibroblasts from periodontal ligament and gingiva is not directly affected by chemokines in vitro. Arch Oral Biol 2007; 52: 663-668.
6. Takagi M, Santavirta S, Ida H, et al. The membranetype- matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodelling in loose total-hip prostheses. Lab Invest 1998;78: 735-742.
7. Izakovicova Holla L, Buckova D, Fassmann A, Benes P, Znojil V. Plasminogen-activator-inhibitor-1 promoter polymorphism as a risk factor for adult periodontitis in non-smokers. Genes Immun 2002;3: 292-294.
8. Buduneli N, Buduneli E, Kardesler L, Lappin D, Kinane DF. Plasminogen activator system in smokers and non-smokers with and without periodontal disease. J Clin Periodontol 2005;32: 417-424.
9. Hundsdorfer B, Zeilhofer H-F, Bock KP, et al. Tumorassociated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity-Clinical relevance and prognostic value. J Craniomaxillofacial Surg 2005;33: 191-196.
10. Duffy MJ, Duggan C. The urokinase plasminogen activator system: A rich source of tumor markers for the individualised management of patients with cancer. Clin Biochem 2004;37: 541-548.
11. DeCarlo AA, Cohen JA, Aguado A, Glenn B. Isolation and characterization of human gingival microvascular endothelial cells. J Periodontal Res 2008;43: 246-254.
12. Rateitschak H, Rateitschak EM, Wolf MF. Parodontologie. Farbatlanten der Zahnmedizin. Stuttgart: Thieme, 1989: vol 1, ed 2.
13. Deppe H, Wagenpfeil S, Donath K.Comparative value of attachment measurements in implant dentistry. Int J Oral Maxillofac Implants 2004;19: 208-215.
14. Grucia B, Wang HY, Lang NP, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res 2004;15: 393-400.
15. Beikler T, Peters U, Prior K, Eisenacher M, Flemmig TF. Gene expression in periodontal tissues following treatment. BMC Med Genomics 2008;1: 30.
16. Gürkan A, Emingil G, Saygan BH, et al. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis. J Periodontol 2007;78: 1256-1263.
17. Papadimitriou S, Tsantarliotou M, Makris G, et al. A clinical study of plasminogen activator activity in gingival tissue in dogs with gingivitis and periodontitis. Res Vet Sci 2006;80: 189-193.
18. DeCarlo AA, Grenett H, Park J, Balton W, Cohen J, Hardigan P. Association of gene polymorphisms for plasminogen activators with alveolar bone loss. J Periodontal Res 2007;42: 305-310.
19. Smith PC, Santibañez JF, Morales JP, Martinez J. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin. J Periodontal Res 2004;39: 380-387.